BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9576284)

  • 21. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.
    Inagawa S; Itabashi M; Adachi S; Kawamoto T; Hori M; Shimazaki J; Yoshimi F; Fukao K
    Clin Cancer Res; 2002 Feb; 8(2):450-6. PubMed ID: 11839663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
    Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA
    J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium.
    Kato Y; Hirano T; Yoshida K; Yashima K; Akimoto S; Tsuji K; Ohira T; Tsuboi M; Ikeda N; Ebihara Y; Kato H
    Lung Cancer; 2005 Jun; 48(3):323-30. PubMed ID: 15893000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma].
    Bae SH; Jung ES; Park YM; Jang JW; Choi JY; Cho SH; Yoon SK; Ahn BM; Cha SB; Chung KW; Sun HS; Park DH; Kim BK; Kim DG
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):297-303. PubMed ID: 12499787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
    Guo C; Liu QG; Yang W; Zhang ZL; Yao YM
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. alpha-, beta- and chi-catenin expression in human pancreatic cancer.
    Julkunen K; Mäkinen K; Kärjä V; Kosma VM; Eskelinen M
    Anticancer Res; 2003; 23(6D):5043-7. PubMed ID: 14981965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of E-cadherin and alpha-,beta- and gamma-catenins in human bladder carcinomas: are they good prognostic factors?
    Mialhe A; Louis J; Montlevier S; Peoch M; Pasquier D; Bosson JL; Rambeaud JJ; Seigneurin D
    Invasion Metastasis; 1997; 17(3):124-37. PubMed ID: 9702939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression.
    Shih HC; Shiozawa T; Miyamoto T; Kashima H; Feng YZ; Kurai M; Konishi I
    Anticancer Res; 2004; 24(6):3843-50. PubMed ID: 15736420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer.
    Syrigos KN; Harrington K; Waxman J; Krausz T; Pignatelli M
    J Urol; 1998 Nov; 160(5):1889-93. PubMed ID: 9783980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular aspects of adhesion-epigenetic mechanisms for inactivation of the E-Cadherin-mediated cell adhesion system in cancers.
    Hirohashi S
    Verh Dtsch Ges Pathol; 2000; 84():28-32. PubMed ID: 11217445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E-cadherin-catenin cell-cell adhesion complex and human cancer.
    Wijnhoven BP; Dinjens WN; Pignatelli M
    Br J Surg; 2000 Aug; 87(8):992-1005. PubMed ID: 10931041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas.
    Ihara A; Koizumi H; Hashizume R; Uchikoshi T
    Hepatology; 1996 Jun; 23(6):1441-7. PubMed ID: 8675162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E-cadherin mediated adhesion system in cancer cells.
    Shiozaki H; Oka H; Inoue M; Tamura S; Monden M
    Cancer; 1996 Apr; 77(8 Suppl):1605-13. PubMed ID: 8608551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival.
    Richmond PJ; Karayiannakis AJ; Nagafuchi A; Kaisary AV; Pignatelli M
    Cancer Res; 1997 Aug; 57(15):3189-93. PubMed ID: 9242448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity.
    Bagutti C; Speight PM; Watt FM
    J Pathol; 1998 Sep; 186(1):8-16. PubMed ID: 9875134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis.
    Nam JS; Ino Y; Sakamoto M; Hirohashi S
    Clin Cancer Res; 2002 Jul; 8(7):2430-6. PubMed ID: 12114449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
    Liu J; Ikeguchi M; Nakamura S; Kaibara N
    J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
    Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO
    J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of ezrin and E-cadherin expression by IL-1beta and TGF-beta1 in human trophoblasts.
    Karmakar S; Das C
    J Reprod Immunol; 2004 Dec; 64(1-2):9-29. PubMed ID: 15596224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.